SEC Comment Letter for PharmaCyte Biotech, Inc. (PMCB) (CIK 0001157075) (PMCB) — Apr 28, 2011

PharmaCyte Biotech, Inc. (PMCB) (CIK 0001157075)
Date: April 28, 2011 · CIK: 0001157075 · Accession: 0000000000-11-026681

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-68008

Date

April 28, 2011

Author

Not clearly detected

Form

UPLOAD

Company

PharmaCyte Biotech, Inc. (PMCB) (CIK 0001157075)

Letter

April 28, 2011 Patricia Gruden Interim Chief Executive Officer Nuvilex, Inc. 1907 N Underwood Ct Payson, AZ 85541

Re: Nuvilex, Inc. Item 4.02 Form 8-K Filed January 31, 2011 File No. 333-68008

Dear Ms. Gruden: We have completed our review of your fili ng and do not have any further comments at this time. Sincerely,

V a n e s s a R o b e r t s o n S t a f f A c c o u n t a n t

Show Raw Text

April 28, 2011

Patricia Gruden
Interim Chief Executive Officer
Nuvilex, Inc.
1907 N Underwood Ct
Payson, AZ 85541

Re: Nuvilex, Inc.
Item 4.02 Form 8-K   Filed January 31, 2011
  File No. 333-68008

Dear Ms. Gruden:
 We have completed our review of your fili ng and do not have any further comments at
this time.
Sincerely,

        V a n e s s a  R o b e r t s o n          S t a f f  A c c o u n t a n t

SecProbe.io